Grant: Discovery Grants Program - Individual
Université Laval
$70,000.00
Studies in organic synthesis
EF 2012-13
Résumé
The ultimate challenge of this century in total synthesis of complex natural products and related compounds is to be able to debunk the myth that such compounds are not economically viable targets in the pharmaceutical industry (S. Baran. J. Org. Chem. 2010, 75, 4657).
Accordingly, we are currently exploring the generality of a powerful synthetic cycloaddition reaction for the rapid construction of natural and non-natural steroids and higher terpenoids. This novel anionic-based cycloaddition reaction discovered in our laboratory leads to polycyclic compounds in one or two-steps by combining two building blocks (mono or bicyclic) with complete control of chirality. Being highly convergent, this new synthetic strategy can be used for target-oriented synthesis of selected natural products to demonstrate its value and later on for diversity oriented synthesis for the discovery of new biological active compounds in industry.
In order to demonstrate the potential of this novel strategy, we have recently reported the first total synthesis of Ouabain (Angew. Chem. Int. Ed. 2008, 47, 1272). This complex cardioactive steroid recently being identified as a human endogenous hormone has a direct link with hypertension. This novel chemical knowledge has led to the elaboration of research project on hypertension and on the study of the biosynthetic pathway of endogenous Ouabain. We have also completed the total synthesis of Hippuristanol, a steroid that could lead to develop novel-mechanism-based anticancer drugs. We are also working on the synthesis of the anticancer agent, Bruceantin, the neurotoxin Batrachotoxin, the anticancer agent Taxol and related analogues.
We have also a renewed interest to investigate novel aspect of stereoelectronic effects in relation with conformation and reactivity of a large number of organic functional groups.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
2837-2011
Name nom
Deslongchamps, Pierre
Department département
Chimie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
70000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
2
Nb partie
5
Application title
Studies in organic synthesis
Keyword
NSERC
Application summary
The ultimate challenge of this century in total synthesis of complex natural products and related compounds is to be able to debunk the myth that such compounds are not economically viable targets in the pharmaceutical industry (S. Baran. J. Org. Chem. 2010, 75, 4657).
Accordingly, we are currently exploring the generality of a powerful synthetic cycloaddition reaction for the rapid construction of natural and non-natural steroids and higher terpenoids. This novel anionic-based cycloaddition reaction discovered in our laboratory leads to polycyclic compounds in one or two-steps by combining two building blocks (mono or bicyclic) with complete control of chirality. Being highly convergent, this new synthetic strategy can be used for target-oriented synthesis of selected natural products to demonstrate its value and later on for diversity oriented synthesis for the discovery of new biological active compounds in industry.
In order to demonstrate the potential of this novel strategy, we have recently reported the first total synthesis of Ouabain (Angew. Chem. Int. Ed. 2008, 47, 1272). This complex cardioactive steroid recently being identified as a human endogenous hormone has a direct link with hypertension. This novel chemical knowledge has led to the elaboration of research project on hypertension and on the study of the biosynthetic pathway of endogenous Ouabain. We have also completed the total synthesis of Hippuristanol, a steroid that could lead to develop novel-mechanism-based anticancer drugs. We are also working on the synthesis of the anticancer agent, Bruceantin, the neurotoxin Batrachotoxin, the anticancer agent Taxol and related analogues.
We have also a renewed interest to investigate novel aspect of stereoelectronic effects in relation with conformation and reactivity of a large number of organic functional groups.